1 |
Pyridoxal phosphate hydrate
| 1件: Pyridoxal phosphate Pyridoxal phosphate | 0件: | - | - | 1件: 13 13 |
2 |
Phenylalanine
| 1件: Phenylalanine Phenylalanine | 1件: Phenylalanine Phenylalanine; | - | - | 2件: 75 75, 240 |
3 |
Phenol
| - | 0件: | - | - | - |
4 |
Proline
| 1件: Proline Proline | 1件: Proline Proline; | - | - | 2件: 94 94, 97 |
5 |
Progesterone
| 1件: Progesterone Progesterone | 1件: Progesterone Progesterone; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 76 76 |
6 |
Propylene glycol
| 1件: Propylene glycol Propylene glycol | 1件: Propylene glycol Propylene glycol; | - | - | 2件: 28 28, 51 |
7 |
Piroxicam
| - | 0件: | - | - | - |
8 |
Pregnenolone
| - | 0件: | - | - | - |
9 |
Pyrazinamide
| - | 0件: | - | - | - |
10 |
Phytonadione
| 1件: Phylloquinone Phylloquinone | 4件: Phylloquinone Phylloquinone; Phytomenadione; Vitamin K; Vitamin K1; | - | - | 6件: 13 13, 46, 96, 97, 288, 299 |
11 |
Parachlorophenol
| - | 0件: | - | - | - |
12 |
Phloroglucinol
| - | 0件: | - | - | - |
13 |
Pentostatin
| - | 0件: | - | - | - |
14 |
Protirelin
| 1件: Protirelin Protirelin | 1件: Thyrotropin releasing hormone Thyrotropin releasing hormone; | 1件: TRHR TRHR 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 80 80 |
15 |
Phenylethyl alcohol
| - | 0件: | - | - | - |
16 |
Physostigmine
| - | 0件: | - | - | - |
17 |
Piperacillin sodium
| 1件: Piperacillin Piperacillin | 1件: PIPERACILLIN PIPERACILLIN; | - | - | 1件: 299 299 |
18 |
Pipobroman
| - | 0件: | - | - | - |
19 |
Plicamycin
| - | 0件: | - | - | - |
20 |
Pralidoxime chloride
| - | 0件: | - | - | - |
21 |
Prazepam
| - | 0件: | - | - | - |
22 |
Praziquantel
| - | 0件: | - | - | - |
23 |
Prednisolone
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
24 |
Prednisone
| 1件: Prednisone Prednisone | 3件: Prednisona Prednisona; PREDNISONE; RAYOS; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
25 |
Primidone
| - | 0件: | - | - | - |
26 |
Probenecid
| 1件: Probenecid Probenecid | 1件: Probenecid Probenecid; | - | - | 1件: 25 25 |
27 |
Probucol
| 1件: Probucol Probucol | 1件: Probucol Probucol; | - | - | 1件: 66 66 |
28 |
Procainamide hydrochloride
| - | 0件: | - | - | - |
29 |
Procarbazine hydrochloride
| 1件: Procarbazine Procarbazine | 1件: Procarbazine Procarbazine; | - | - | 1件: 65 65 |
30 |
Prochlorperazine maleate
| - | 0件: | - | - | - |
31 |
Promethazine hydrochloride
| 1件: Promethazine Promethazine | 1件: Promethazine Promethazine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
32 |
Propantheline bromide
| 1件: Propantheline Propantheline | 2件: Propantheline Propantheline; Propantheline Bromide; | 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 26 26 |
33 |
Propoxyphene hydrochloride
| - | 0件: | - | - | - |
34 |
Propranolol hydrochloride
| 1件: Propranolol Propranolol | 3件: Propanolol Propanolol; Propranolol; Propranolol Hydrochloride; | 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 158, 167, 215, 227, 278, 296 |
35 |
Protriptyline hydrochloride
| - | 0件: | - | - | - |
36 |
Pseudoephedrine hydrochloride
| 1件: Pseudoephedrine Pseudoephedrine | 1件: Pseudoephedrine Pseudoephedrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
37 |
Pyridostigmine bromide
| 1件: Pyridostigmine Pyridostigmine | 3件: Mestinon Mestinon; Pyridostigmine; PYRIDOSTIGMINE BROMIDE; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 4件: 3 3, 6, 11, 256 |
38 |
Pyrimethamine
| 1件: Pyrimethamine Pyrimethamine | 2件: Daraprim Daraprim; PYRIMETHAMINE; | - | - | 11件: 2 2, 4, 6, 13, 19, 46, 51, 65, 96, 97, 265 |
39 |
Paclitaxel
| 1件: Paclitaxel Paclitaxel | 1件: Paclitaxel Paclitaxel; | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 2件: 46 46, 85 |
40 |
Prochlorperazine
| - | 0件: | - | - | - |
41 |
Promethazine
| 1件: Promethazine Promethazine | 1件: Promethazine Promethazine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
42 |
Paramethadione
| - | 0件: | - | - | - |
43 |
Penicillamine
| 1件: Penicillamine Penicillamine | 2件: D-penicillamine D-penicillamine; PENICILLAMINE; | - | - | 2件: 51 51, 171 |
44 |
Penicillin V potassium
| 1件: Phenoxymethylpenicillin Phenoxymethylpenicillin | 0件: | - | - | 3件: 13 13, 97, 215 |
45 |
Pentazocine
| - | 0件: | - | - | - |
46 |
Pentobarbital
| - | 0件: | - | - | - |
47 |
Pentobarbital sodium
| - | 0件: | - | - | - |
48 |
Pentoxifylline
| 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline Pentoxifylline; | - | - | 10件: 26 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 |
49 |
Pergolide mesylate
| 1件: Pergolide Pergolide | 1件: PERGOLIDE PERGOLIDE; | 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
50 |
Perphenazine
| - | 0件: | - | - | - |
51 |
Phenacemide
| - | 0件: | - | - | - |
52 |
Phenelzine sulfate
| 1件: Phenelzine Phenelzine | 1件: Nardil Nardil; | 2件: MAOA MAOA, MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
53 |
Phenobarbital
| - | 0件: | - | - | - |
54 |
Phenoxybenzamine hydrochloride
| - | 0件: | - | - | - |
55 |
Phensuximide
| - | 0件: | - | - | - |
56 |
Phentolamine mesylate
| - | 0件: | - | - | - |
57 |
Phenylbutazone
| - | 0件: | - | - | - |
58 |
Phenylephrine hydrochloride
| 1件: Phenylephrine Phenylephrine | 1件: Phenylephrine Phenylephrine; | 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 22 22 |
59 |
Phenytoin
| 1件: Phenytoin Phenytoin | 1件: Phenytoin Phenytoin; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 |
60 |
Pindolol
| - | 0件: | - | - | - |
61 |
Pilocarpine
| 1件: Pilocarpine Pilocarpine | 2件: Pilocarpine Pilocarpine; Pilocarpine Hydrochloride; | 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 53, 299 |
62 |
Propofol
| 1件: Propofol Propofol | 2件: Propofol Propofol; Propofol Injection; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 10件: 6 6, 21, 22, 34, 46, 70, 75, 84, 98, 296 |
63 |
Prilocaine
| - | 0件: | - | - | - |
64 |
Pramipexole dihydrochloride
| 1件: Pramipexole Pramipexole | 7件: Mirapex Mirapex; Mirapex ER; Mirapexin; Pramipexol; Pramipexole; PRAMIPEXOLE DIHYDROCHLORIDE; SIFROL; | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 20 |
65 |
Pimozide
| 1件: Pimozide Pimozide | 1件: Pimozide Pimozide; | 2件: ADRA2A ADRA2A, DRD2 💬 | 9件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
66 |
Propylthiouracil
| - | 0件: | - | - | - |
67 |
Phenacetin
| - | 0件: | - | - | - |
68 |
Prazosin hydrochloride
| - | 0件: | - | - | - |
69 |
Perindopril erbumine
| 1件: Perindopril Perindopril | 2件: Coversyl Coversyl; Perindopril; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 4件: 58 58, 113, 167, 222 |
70 |
Propafenone hydrochloride
| - | 0件: | - | - | - |
71 |
Polythiazide
| - | 0件: | - | - | - |
72 |
Paraldehyde
| - | 0件: | - | - | - |
73 |
Procaine hydrochloride
| - | 0件: | - | - | - |
74 |
Pemoline
| - | 0件: | - | - | - |
75 |
Procyclidine hydrochloride
| - | 0件: | - | - | - |
76 |
Promazine hydrochloride
| - | 0件: | - | - | - |
77 |
Piperazine
| 1件: Piperazine Piperazine | 1件: Piperazine Piperazine; | - | - | 2件: 58 58, 272 |
78 |
Pentamidine isethionate
| 1件: Pentamidine Pentamidine | 2件: Pentamidina Pentamidina; Pentamidine; | - | - | 2件: 61 61, 65 |
79 |
Povidone-iodine
| - | 0件: | - | - | - |
80 |
Pravastatin sodium
| 1件: Pravastatin Pravastatin | 2件: Pravastatin Pravastatin; Pravastatin sodium; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 9件: 13 13, 46, 49, 67, 79, 96, 164, 265, 333 |
81 |
Paricalcitol
| 1件: Paricalcitol Paricalcitol | 1件: Paricalcitol Paricalcitol; | 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 4件: 19 19, 66, 218, 238 |
82 |
Pamidronate disodium
| 1件: Pamidronic acid Pamidronic acid | 1件: Pamidronate Pamidronate; | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 270 270, 271, 274 |
83 |
Pioglitazone hydrochloride
| 1件: Pioglitazone Pioglitazone | 1件: PIOGLITAZONE PIOGLITAZONE; | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
84 |
Prednisolone acetate
| 2件: Prednisolone Prednisolone, Prednisolone acetate | 4件: Prednisolona Prednisolona; Prednisolone; PREDNISOLONE ACETATE; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 44件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 222, 269, 271, 296, 299, 300, 307 |
85 |
Prednisolone sodium phosphate
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
86 |
Prednisolone tebutate
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
87 |
Potassium iodide
| - | 0件: | - | - | - |
88 |
Penicillin G potassium
| 1件: Benzylpenicillin Benzylpenicillin | 0件: | - | - | 1件: 46 46 |
89 |
Polymyxin B sulfate
| - | 0件: | - | - | - |
90 |
Polysorbate 80
| - | 0件: | - | - | - |
91 |
Pemirolast potassium
| 1件: Pemirolast Pemirolast | 1件: PEMIROLAST PEMIROLAST; | - | - | 1件: 113 113 |
92 |
Pyrrolnitrin
| - | 0件: | - | - | - |
93 |
Pirenoxine
| - | 0件: | - | - | - |
94 |
Profenamine hydrochloride
| - | 0件: | - | - | - |
95 |
Pimobendan
| - | 0件: | - | - | - |
96 |
Prulifloxacin
| - | 0件: | - | - | - |
97 |
Pazufloxacin
| - | 0件: | - | - | - |
98 |
Potassium acetate
| - | 0件: | - | - | - |
99 |
Potassium hydroxide
| - | 0件: | - | - | - |
100 |
Prothionamide
| - | 0件: | - | - | - |
101 |
Phenolsulfonphthalein
| - | 0件: | - | - | - |
102 |
Phenylpropanolamine hydrochloride
| - | 0件: | - | - | - |
103 |
Paramethasone acetate
| - | 0件: | - | - | - |
104 |
Pantethine
| 1件: Pantethine Pantethine | 1件: Pantethine Pantethine; | - | - | 1件: 120 120 |
105 |
Prednisolone sodium succinate
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
106 |
Promethazine teoclate
| 1件: Promethazine Promethazine | 1件: Promethazine Promethazine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
107 |
Prilocaine hydrochloride
| - | 0件: | - | - | - |
108 |
Pirenzepine hydrochloride
| - | 0件: | - | - | - |
109 |
Potassium gluconate
| - | 0件: | - | - | - |
110 |
Proscillaridin
| - | 0件: | - | - | - |
111 |
Piperazine phosphate
| 1件: Piperazine Piperazine | 1件: Piperazine Piperazine; | - | - | 2件: 58 58, 272 |
112 |
Phenolsulfonic acid
| - | 0件: | - | - | - |
113 |
Propyl parahydroxybenzoate
| - | 0件: | - | - | - |
114 |
Piromidic acid
| - | 0件: | - | - | - |
115 |
Propericiazine
| - | 0件: | - | - | - |
116 |
Potassium bitartrate
| - | 0件: | - | - | - |
117 |
Pralidoxime iodide
| - | 0件: | - | - | - |
118 |
Pranoprofen
| - | 0件: | - | - | - |
119 |
Pirfenidone
| 1件: Pirfenidone Pirfenidone | 2件: Esbriet Esbriet; Pirfenidone; | 6件: CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | 84件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
120 |
Potassium guaiacolsulfonate
| - | 0件: | - | - | - |
121 |
Polaprezinc
| 1件: Polaprezinc Polaprezinc | 1件: Polaprezinc Polaprezinc; | - | - | 2件: 96 96, 97 |
122 |
Propentofylline
| - | 0件: | - | - | - |
123 |
Pentagastrin
| - | 0件: | - | - | - |
124 |
Piretanide
| - | 0件: | - | - | - |
125 |
Pentaerythritol tetranitrate
| - | 0件: | - | - | - |
126 |
Potassium sulfate
| - | 0件: | - | - | - |
127 |
Perflutren
| 1件: Perflutren Perflutren | 1件: Optison Optison; | - | - | 1件: 96 96 |
128 |
Propyliodone
| - | 0件: | - | - | - |
129 |
Proxyphylline
| - | 0件: | - | - | - |
130 |
Proglumide
| - | 0件: | - | - | - |
131 |
Phenprobamate
| - | 0件: | - | - | - |
132 |
Pentamycin
| - | 0件: | - | - | - |
133 |
Pentetreotide
| 1件: Pentetreotide Pentetreotide | 1件: Pentetreotide Pentetreotide; | - | - | 1件: 75 75 |
134 |
Pelubiprofen
| 1件: Pelubiprofen Pelubiprofen | 1件: Pelubiprofen Pelubiprofen; | - | - | 1件: 46 46 |
135 |
Pirarubicin
| - | 0件: | - | - | - |
136 |
Piracetam
| - | 0件: | - | - | - |
137 |
Polidocanol
| 1件: Polidocanol Polidocanol | 1件: Polidocanol Polidocanol; | - | - | 1件: 279 279 |
138 |
Prednisolone farnesylate
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
139 |
Prochlorperazine mesilate
| - | 0件: | - | - | - |
140 |
Perphenazine maleate
| - | 0件: | - | - | - |
141 |
Potassium carbonate
| 1件: Potassium carbonate Potassium carbonate | 0件: | - | - | 3件: 6 6, 96, 291 |
142 |
Potassium nitrate
| - | 0件: | - | - | - |
143 |
Potassium permanganate
| - | 0件: | - | - | - |
144 |
Potassium chloride
| - | 0件: | - | - | - |
145 |
Potassium bicarbonate
| - | 0件: | - | - | - |
146 |
Phenytoin sodium
| 1件: Phenytoin Phenytoin | 1件: Phenytoin Phenytoin; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 |
147 |
Pentazocine lactate
| - | 0件: | - | - | - |
148 |
Penciclovir sodium
| 1件: Penciclovir Penciclovir | 0件: | - | - | 1件: 13 13 |
149 |
Primaquine phosphate
| - | 0件: | - | - | - |
150 |
Piperazine citrate
| 1件: Piperazine Piperazine | 1件: Piperazine Piperazine; | - | - | 2件: 58 58, 272 |
151 |
Piperazine adipate
| 1件: Piperazine Piperazine | 1件: Piperazine Piperazine; | - | - | 2件: 58 58, 272 |
152 |
Prednisolone hemisuccinate
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
153 |
Penicillin G benzathine
| 1件: Benzylpenicillin Benzylpenicillin | 0件: | - | - | 1件: 46 46 |
154 |
Pyrithioxine
| - | 0件: | - | - | - |
155 |
Pyridoxine hydrochloride
| 1件: Pyridoxine Pyridoxine | 2件: Pyridoxine Pyridoxine; Vitamin B6; | - | - | 5件: 6 6, 93, 145, 206, 320 |
156 |
Pilocarpine hydrochloride
| 1件: Pilocarpine Pilocarpine | 2件: Pilocarpine Pilocarpine; Pilocarpine Hydrochloride; | 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 53, 299 |
157 |
Papaverine hydrochloride
| - | 0件: | - | - | - |
158 |
Protamine sulfate
| - | 0件: | - | - | - |
159 |
Pentazocine hydrochloride
| - | 0件: | - | - | - |
160 |
Piperacillin
| 1件: Piperacillin Piperacillin | 1件: PIPERACILLIN PIPERACILLIN; | - | - | 1件: 299 299 |
161 |
Pentobarbital calcium
| - | 0件: | - | - | - |
162 |
Paroxetine hydrochloride hemihydrate
| 1件: Paroxetine Paroxetine | 1件: Paroxetine Paroxetine; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 |
163 |
Povidone
| - | 0件: | - | - | - |
164 |
Pefloxacin
| - | 0件: | - | - | - |
165 |
Pefloxacin mesylate
| - | 0件: | - | - | - |
166 |
Propionic acid
| 1件: Propanoic acid Propanoic acid | 1件: Propanoic acid Propanoic acid; | - | - | 2件: 6 6, 271 |
167 |
Pectin
| 1件: Pectin Pectin | 1件: Pectin Pectin; | - | - | 1件: 96 96 |
168 |
Polyvinyl alcohol
| - | 0件: | - | - | - |
169 |
Propiomazine
| - | 0件: | - | - | - |
170 |
Paroxetine
| 1件: Paroxetine Paroxetine | 1件: Paroxetine Paroxetine; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 |
171 |
Propyl gallate
| - | 0件: | - | - | - |
172 |
Prenylamine
| - | 0件: | - | - | - |
173 |
Physostigmine salicylate
| - | 0件: | - | - | - |
174 |
Phthalylsulfathiazole
| - | 0件: | - | - | - |
175 |
Proguanil hydrochloride
| - | 0件: | - | - | - |
176 |
Phenoxymethylpenicillin benzathine
| 1件: Phenoxymethylpenicillin Phenoxymethylpenicillin | 0件: | - | - | 3件: 13 13, 97, 215 |
177 |
Posaconazole
| 1件: Posaconazole Posaconazole | 2件: Noxafil Noxafil; Posaconazole; | - | - | 4件: 60 60, 65, 96, 299 |
178 |
Pantoprazole sodium
| 1件: Pantoprazole Pantoprazole | 1件: Pantoprazole Pantoprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 13 13, 65 |
179 |
Phenothiazine
| 1件: Phenothiazine Phenothiazine | 1件: Phenothiazine Phenothiazine; | - | - | 1件: 127 127 |
180 |
Prochlorperazine edisylate
| - | 0件: | - | - | - |
181 |
Phenoperidine
| - | 0件: | - | - | - |
182 |
Pagoclone
| - | 0件: | - | - | - |
183 |
Pipamperone
| - | 0件: | - | - | - |
184 |
Penfluridol
| - | 0件: | - | - | - |
185 |
Pregabalin
| 1件: Pregabalin Pregabalin | 2件: Lyrica Lyrica; Pregabalin; | 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 5件: 13 13, 36, 46, 70, 298 |
186 |
Palivizumab
| - | 0件: | - | - | - |
187 |
Peginterferon alfa-2a
| - | 0件: | - | - | - |
188 |
Peginterferon alfa-2b
| - | 0件: | - | - | - |
189 |
Promethazine methylenedisalicylate
| 1件: Promethazine Promethazine | 1件: Promethazine Promethazine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
190 |
Prednisolone valerate acetate
| 1件: Prednisolone Prednisolone | 3件: Prednisolona Prednisolona; PREDNISOLONE; Prednisolonum; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
191 |
Peanut oil
| - | 0件: | - | - | - |
192 |
Porfimer sodium
| - | 0件: | - | - | - |
193 |
Polyethylene glycol 3350
| 1件: Polyethylene glycol Polyethylene glycol | 4件: Macrogol Macrogol; Macrogol 4000; Polyethylene glycol; Polyethylene Glycol 3350; | - | - | 14件: 6 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 235, 240, 276, 299 |
194 |
Peracetic acid
| - | 0件: | - | - | - |
195 |
Parecoxib
| 1件: Parecoxib Parecoxib | 1件: Parecoxib Parecoxib; | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 |
196 |
Panthenol
| - | 0件: | - | - | - |
197 |
Perindopril
| 1件: Perindopril Perindopril | 2件: Coversyl Coversyl; Perindopril; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 4件: 58 58, 113, 167, 222 |
198 |
Prinomastat
| - | 0件: | - | - | - |
199 |
Pemetrexed disodium
| - | 0件: | - | - | - |
200 |
Peramivir
| - | 0件: | - | - | - |
201 |
Perphenazine fendizoate
| - | 0件: | - | - | - |
202 |
Pine tar
| - | 0件: | - | - | - |
203 |
Potassium L-aspartate
| - | 0件: | - | - | - |
204 |
Perphenazine hydrochloride
| - | 0件: | - | - | - |
205 |
Pirenzepine hydrochloride hydrate
| - | 0件: | - | - | - |
206 |
Petrolatum
| 1件: Petrolatum Petrolatum | 1件: Petrolatum Petrolatum; | - | - | 3件: 35 35, 158, 162 |
207 |
Paclitaxel poliglumex
| 1件: Paclitaxel Paclitaxel | 1件: Paclitaxel Paclitaxel; | 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 2件: 46 46, 85 |
208 |
Padimate A
| - | 0件: | - | - | - |
209 |
Padimate O
| - | 0件: | - | - | - |
210 |
Palifermin
| 1件: Palifermin Palifermin | 2件: Kepivance Kepivance; Palifermin; | 1件: FGFR2 FGFR2 💬 | 13件: Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | 5件: 13 13, 36, 38, 39, 65 |
211 |
Paliperidone
| - | 0件: | - | - | - |
212 |
Palmitic acid
| 1件: Palmitic Acid Palmitic Acid | 1件: Palmitate Palmitate; | - | - | 1件: 63 63 |
213 |
Pancrelipase
| 1件: Pancrelipase Pancrelipase | 2件: Pancreatin Pancreatin; Pancrelipase; | - | - | 2件: 298 298, 299 |
214 |
Panitumumab
| - | 0件: | - | - | - |
215 |
Pantoprazole
| 1件: Pantoprazole Pantoprazole | 1件: PANTOPRAZOLE PANTOPRAZOLE; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 13 13, 65 |
216 |
Papain
| - | 0件: | - | - | - |
217 |
Parathyroid hormone
| 1件: Parathyroid hormone Parathyroid hormone | 5件: Natpar Natpar; Natpara; Parathyroid hormone; PREOTACT; RhPTH; | 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 4件: 65 65, 70, 235, 326 |
218 |
Paroxetine hydrochloride
| 1件: Paroxetine Paroxetine | 1件: Paroxetine Paroxetine; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 |
219 |
Paroxetine mesylate
| 1件: Paroxetine Paroxetine | 1件: Paroxetine Paroxetine; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 |
220 |
Pascolizumab
| - | 0件: | - | - | - |
221 |
Pegademase bovine
| 1件: Pegademase Pegademase | 1件: Adagen Adagen; | - | - | 1件: 65 65 |
222 |
Pegamotecan
| - | 0件: | - | - | - |
223 |
Pegaspargase
| - | 0件: | - | - | - |
224 |
Pegsunercept
| 1件: Pegsunercept Pegsunercept | 2件: Pegsunercept Pegsunercept; STNF-R1; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
225 |
Pegvisomant
| 1件: Pegvisomant Pegvisomant | 1件: Pegvisomant Pegvisomant; | 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
226 |
Peldesine
| - | 0件: | - | - | - |
227 |
Pelitinib
| - | 0件: | - | - | - |
228 |
Pelitrexol
| - | 0件: | - | - | - |
229 |
Penamecillin
| - | 0件: | - | - | - |
230 |
Penciclovir
| 1件: Penciclovir Penciclovir | 0件: | - | - | 1件: 13 13 |
231 |
Penicillin V
| 1件: Phenoxymethylpenicillin Phenoxymethylpenicillin | 0件: | - | - | 3件: 13 13, 97, 215 |
232 |
Pentetic acid
| 1件: Pentetic acid Pentetic acid | 1件: DTPA DTPA; | - | - | 2件: 28 28, 299 |
233 |
Pentosan polysulfate sodium
| 1件: Pentosan polysulfate Pentosan polysulfate | 1件: Pentosan polysulfate Pentosan polysulfate; | - | - | 3件: 19 19, 26, 226 |
234 |
Peppermint oil
| 1件: Peppermint oil Peppermint oil | 1件: Peppermint oil Peppermint oil; | - | - | 1件: 226 226 |
235 |
Perflenapent
| - | 0件: | - | - | - |
236 |
Perflexane
| - | 0件: | - | - | - |
237 |
Perflubron
| - | 0件: | - | - | - |
238 |
Perflubutane
| 1件: Perflubutane Perflubutane | 1件: Perflubutane Perflubutane; | - | - | 2件: 298 298, 300 |
239 |
Perfosfamide
| - | 0件: | - | - | - |
240 |
Perhexiline maleate
| 1件: Perhexiline Perhexiline | 1件: Perhexiline Perhexiline; | 8件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 | 47件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 58 58, 272 |
241 |
Permethrin
| - | 0件: | - | - | - |
242 |
Pertuzumab
| - | 0件: | - | - | - |
243 |
Perzinfotel
| - | 0件: | - | - | - |
244 |
Phenolphthalein
| - | 0件: | - | - | - |
245 |
Phenprocoumon
| - | 0件: | - | - | - |
246 |
Phentermine
| 1件: Phentermine Phentermine | 1件: Phentermine Phentermine; | 5件: MAOA MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 97 97 |
247 |
Phentermine hydrochloride
| 1件: Phentermine Phentermine | 1件: Phentermine Phentermine; | 5件: MAOA MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 97 97 |
248 |
Phenyl aminosalicylate
| - | 0件: | - | - | - |
249 |
Phenylmercuric nitrate
| - | 0件: | - | - | - |
250 |
Phenylpropanolamine polistirex
| - | 0件: | - | - | - |
251 |
Phosphoric acid
| - | 0件: | - | - | - |
252 |
Phthalofyne
| - | 0件: | - | - | - |
253 |
Piclamilast
| - | 0件: | - | - | - |
254 |
Pilocarpine nitrate
| 1件: Pilocarpine Pilocarpine | 2件: Pilocarpine Pilocarpine; Pilocarpine Hydrochloride; | 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 53, 299 |
255 |
Pimecrolimus
| 1件: Pimecrolimus Pimecrolimus | 1件: Pimecrolimus Pimecrolimus; | 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 160 160 |
256 |
Pinacidil
| - | 0件: | - | - | - |
257 |
Pipazethate
| - | 0件: | - | - | - |
258 |
Piperazine edetate calcium
| 1件: Piperazine Piperazine | 1件: Piperazine Piperazine; | - | - | 2件: 58 58, 272 |
259 |
Piprozolin
| - | 0件: | - | - | - |
260 |
Pirnabine
| - | 0件: | - | - | - |
261 |
Piroctone
| - | 0件: | - | - | - |
262 |
Pirodavir
| - | 0件: | - | - | - |
263 |
Piroxicam betadex
| - | 0件: | - | - | - |
264 |
Piroxicam cinnamate
| - | 0件: | - | - | - |
265 |
Piroxicam olamine
| - | 0件: | - | - | - |
266 |
Pirprofen
| - | 0件: | - | - | - |
267 |
Pixantrone
| 1件: Pixantrone Pixantrone | 1件: Pixantrone Pixantrone; | 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 2件: 11 11, 13 |
268 |
Pizotyline
| - | 0件: | - | - | - |
269 |
Plantago seed
| 1件: Plantago seed Plantago seed | 2件: Psyllium Psyllium; Psyllium husk; | - | - | 3件: 6 6, 28, 97 |
270 |
Pleconaril
| 1件: Pleconaril Pleconaril | 1件: PLECONARIL PLECONARIL; | - | - | 1件: 2 2 |
271 |
Podofilox
| - | 0件: | - | - | - |
272 |
Polifeprosan 20
| - | 0件: | - | - | - |
273 |
Poliglusam
| - | 0件: | - | - | - |
274 |
Poloxalene
| - | 0件: | - | - | - |
275 |
Polydextrose
| - | 0件: | - | - | - |
276 |
Polydioxanone
| - | 0件: | - | - | - |
277 |
Polysorbate 20
| - | 0件: | - | - | - |
278 |
Polysorbate 60
| - | 0件: | - | - | - |
279 |
Porfiromycin
| - | 0件: | - | - | - |
280 |
Pramipexole
| 1件: Pramipexole Pramipexole | 7件: Mirapex Mirapex; Mirapex ER; Mirapexin; Pramipexol; PRAMIPEXOLE; PRAMIPEXOLE DIHYDROCHLORIDE; SIFROL; | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 20 |
281 |
Potassium citrate
| - | 0件: | - | - | - |
282 |
Potassium guaiacolsulfonate
| - | 0件: | - | - | - |
283 |
Potassium metabisulfite
| - | 0件: | - | - | - |
284 |
Practolol
| - | 0件: | - | - | - |
285 |
Pradefovir mesylate
| - | 0件: | - | - | - |
286 |
Pralatrexate
| - | 0件: | - | - | - |
287 |
Pralidoxime mesylate
| - | 0件: | - | - | - |
288 |
Pramlintide
| - | 0件: | - | - | - |
289 |
Pramlintide acetate
| - | 0件: | - | - | - |
290 |
Prednicarbate
| - | 0件: | - | - | - |
291 |
Prednimustine
| - | 0件: | - | - | - |
292 |
Progabide
| - | 0件: | - | - | - |
293 |
Propanidid
| - | 0件: | - | - | - |
294 |
Propatyl nitrate
| - | 0件: | - | - | - |
295 |
Propiolactone
| - | 0件: | - | - | - |
296 |
Propylhexedrine
| - | 0件: | - | - | - |
297 |
Proquazone
| - | 0件: | - | - | - |
298 |
Prostalene
| - | 0件: | - | - | - |
299 |
Protein hydrolysate
| - | 0件: | - | - | - |
300 |
Proxazole
| - | 0件: | - | - | - |
301 |
Pseudoephedrine polistirex
| 1件: Pseudoephedrine Pseudoephedrine | 1件: Pseudoephedrine Pseudoephedrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
302 |
Pseudoephedrine sulfate
| 1件: Pseudoephedrine Pseudoephedrine | 1件: Pseudoephedrine Pseudoephedrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
303 |
Pumice
| - | 0件: | - | - | - |
304 |
Puromycin
| - | 0件: | - | - | - |
305 |
Pyrethrum extract
| - | 0件: | - | - | - |
306 |
Peretinoin
| - | 0件: | - | - | - |
307 |
Pentastarch
| - | 0件: | - | - | - |
308 |
Polycarbophil
| - | 0件: | - | - | - |
309 |
Podophyllum resin
| - | 0件: | - | - | - |
310 |
Polyoxyethylene (160) polyoxypropylene (30) glycol
| - | 0件: | - | - | - |
311 |
Pemetrexed sodium hydrate
| - | 0件: | - | - | - |
312 |
Pertussis vaccine
| 1件: Pertussis vaccine Pertussis vaccine | 1件: Pertussis vaccine Pertussis vaccine; | - | - | 2件: 13 13, 46 |
313 |
Pramiconazole
| - | 0件: | - | - | - |
314 |
Prinaberel
| - | 0件: | - | - | - |
315 |
Pruvanserin
| - | 0件: | - | - | - |
316 |
Pegfilgrastim
| 1件: Pegfilgrastim Pegfilgrastim | 1件: Pegfilgrastim Pegfilgrastim; | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 60 60 |
317 |
Picotamide
| - | 0件: | - | - | - |
318 |
Pentifylline
| - | 0件: | - | - | - |
319 |
Palonosetron
| - | 0件: | - | - | - |
320 |
Propamidine
| - | 0件: | - | - | - |
321 |
Policresulen
| - | 0件: | - | - | - |
322 |
Phenylmercuric borate
| - | 0件: | - | - | - |
323 |
Protiofate
| - | 0件: | - | - | - |
324 |
Promestriene
| - | 0件: | - | - | - |
325 |
Prednylidene
| - | 0件: | - | - | - |
326 |
Potassium perchlorate
| - | 0件: | - | - | - |
327 |
Penimepicycline
| - | 0件: | - | - | - |
328 |
Pidotimod
| - | 0件: | - | - | - |
329 |
Pamidronic acid
| 1件: Pamidronic acid Pamidronic acid | 1件: Pamidronate Pamidronate; | 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 270 270, 271, 274 |
330 |
Piritramide
| - | 0件: | - | - | - |
331 |
Propacetamol
| - | 0件: | - | - | - |
332 |
Phenglutarimide
| - | 0件: | - | - | - |
333 |
Piribedil
| 1件: Piribedil Piribedil | 1件: Piribedil Piribedil; | 2件: DRD2 DRD2, DRD3 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
334 |
Prothipendyl
| - | 0件: | - | - | - |
335 |
Pinazepam
| - | 0件: | - | - | - |
336 |
Proxibarbal
| - | 0件: | - | - | - |
337 |
Pyrithyldione
| - | 0件: | - | - | - |
338 |
Pivagabine
| - | 0件: | - | - | - |
339 |
Pirisudanol
| - | 0件: | - | - | - |
340 |
Phanquinone
| - | 0件: | - | - | - |
341 |
Pholcodine
| - | 0件: | - | - | - |
342 |
Prenoxdiazine
| - | 0件: | - | - | - |
343 |
Pyrrobutamine
| - | 0件: | - | - | - |
344 |
Pimethixene
| - | 0件: | - | - | - |
345 |
Pentetrazol
| - | 0件: | - | - | - |
346 |
Pantothenic acid
| - | 0件: | - | - | - |
347 |
Picloxydine
| - | 0件: | - | - | - |
348 |
Papaverine
| - | 0件: | - | - | - |
349 |
Propenidazole
| - | 0件: | - | - | - |
350 |
Polyestradiol phosphate
| - | 0件: | - | - | - |
351 |
Paramethasone
| - | 0件: | - | - | - |
352 |
Pargeverine
| - | 0件: | - | - | - |
353 |
Paromomycin
| - | 0件: | - | - | - |
354 |
Pemetrexed
| - | 0件: | - | - | - |
355 |
Pemirolast
| 1件: Pemirolast Pemirolast | 1件: PEMIROLAST PEMIROLAST; | - | - | 1件: 113 113 |
356 |
Penbutolol
| - | 0件: | - | - | - |
357 |
Palmidrol
| 1件: Palmidrol Palmidrol | 1件: Palmitoylethanolamide Palmitoylethanolamide; | - | - | 1件: 2 2 |
358 |
Pentamidine
| 1件: Pentamidine Pentamidine | 2件: Pentamidina Pentamidina; Pentamidine; | - | - | 2件: 61 61, 65 |
359 |
Pentoxyverine
| - | 0件: | - | - | - |
360 |
Pergolide
| 1件: Pergolide Pergolide | 1件: PERGOLIDE PERGOLIDE; | 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
361 |
Perhexiline
| 1件: Perhexiline Perhexiline | 1件: Perhexiline Perhexiline; | 8件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 | 47件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 58 58, 272 |
362 |
Perphenazine enantate
| - | 0件: | - | - | - |
363 |
Pethidine
| 1件: Meperidine Meperidine | 1件: Pethidine Pethidine; | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 298 298 |
364 |
Phenazopyridine
| - | 0件: | - | - | - |
365 |
Phendimetrazine
| - | 0件: | - | - | - |
366 |
Phenelzine
| 1件: Phenelzine Phenelzine | 1件: Nardil Nardil; | 2件: MAOA MAOA, MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
367 |
Pheneticillin
| - | 0件: | - | - | - |
368 |
Phenformin
| - | 0件: | - | - | - |
369 |
Phenindamine
| - | 0件: | - | - | - |
370 |
Phenindione
| 1件: Phenindione Phenindione | 0件: | 1件: VKORC1 VKORC1 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 1件: 65 65 |
371 |
Pheniramine
| - | 0件: | - | - | - |
372 |
Phenothrin
| - | 0件: | - | - | - |
373 |
Phenoxybenzamine
| - | 0件: | - | - | - |
374 |
Phenoxyethanol
| - | 0件: | - | - | - |
375 |
Phentolamine
| - | 0件: | - | - | - |
376 |
Phenylephrine
| 1件: Phenylephrine Phenylephrine | 1件: Phenylephrine Phenylephrine; | 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 22 22 |
377 |
Phenylpropanolamine
| - | 0件: | - | - | - |
378 |
Phosmet
| - | 0件: | - | - | - |
379 |
Pilsicainide
| - | 0件: | - | - | - |
380 |
Pioglitazone
| 1件: Pioglitazone Pioglitazone | 1件: Pioglitazone Pioglitazone; | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
381 |
Pipemidic acid
| - | 0件: | - | - | - |
382 |
Piperacillin
| 1件: Piperacillin Piperacillin | 1件: PIPERACILLIN PIPERACILLIN; | - | - | 1件: 299 299 |
383 |
Piperidolate
| - | 0件: | - | - | - |
384 |
Piperonyl butoxide
| - | 0件: | - | - | - |
385 |
Pipethanate
| - | 0件: | - | - | - |
386 |
Pipotiazine
| - | 0件: | - | - | - |
387 |
Pirbuterol
| - | 0件: | - | - | - |
388 |
Pirenzepine
| - | 0件: | - | - | - |
389 |
Pirlimycin
| - | 0件: | - | - | - |
390 |
Pirlindole
| - | 0件: | - | - | - |
391 |
Pivampicillin
| - | 0件: | - | - | - |
392 |
Polihexanide
| - | 0件: | - | - | - |
393 |
Polygeline
| - | 0件: | - | - | - |
394 |
Polymyxin B
| - | 0件: | - | - | - |
395 |
Poractant alfa
| 1件: Poractant alfa Poractant alfa | 1件: Curosurf Curosurf; | - | - | 1件: 211 211 |
396 |
Potassium
| 1件: Potassium Potassium | 1件: Potassium Potassium; | - | - | 12件: 36 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235 |
397 |
Pramiracetam
| - | 0件: | - | - | - |
398 |
Pramocaine
| - | 0件: | - | - | - |
399 |
Pranlukast
| - | 0件: | - | - | - |
400 |
Prasterone
| 1件: Prasterone Prasterone | 3件: Dehydroepiandrosterone Dehydroepiandrosterone; DHEA; Prasterone; | 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 6件: 49 49, 53, 83, 86, 96, 113 |
401 |
Pravastatin
| 1件: Pravastatin Pravastatin | 2件: Pravastatin Pravastatin; Pravastatin sodium; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 9件: 13 13, 46, 49, 67, 79, 96, 164, 265, 333 |
402 |
Prazosin
| - | 0件: | - | - | - |
403 |
Prednisone acetate
| 1件: Prednisone acetate Prednisone acetate | 2件: Cortancyl Cortancyl; Prednisone acetate; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 35 35, 40, 41, 46, 49, 162, 224 |
404 |
Pridinol
| - | 0件: | - | - | - |
405 |
Pridinol hydrochloride
| - | 0件: | - | - | - |
406 |
Primaquine
| - | 0件: | - | - | - |
407 |
Procainamide
| - | 0件: | - | - | - |
408 |
Procaine
| - | 0件: | - | - | - |
409 |
Procarbazine
| 1件: Procarbazine Procarbazine | 1件: Procarbazine Procarbazine; | - | - | 1件: 65 65 |
410 |
Procaterol
| - | 0件: | - | - | - |
411 |
Procyclidine
| - | 0件: | - | - | - |
412 |
Profenamine
| - | 0件: | - | - | - |
413 |
Proglumetacin
| - | 0件: | - | - | - |
414 |
Proguanil
| - | 0件: | - | - | - |
415 |
Promazine
| - | 0件: | - | - | - |
416 |
Promegestone
| - | 0件: | - | - | - |
417 |
Propafenone
| - | 0件: | - | - | - |
418 |
Propicillin
| - | 0件: | - | - | - |
419 |
Propiverine
| 1件: Propiverine Propiverine | 1件: Propiverine Propiverine; | 9件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 43件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
420 |
Propranolol
| 1件: Propranolol Propranolol | 3件: Propanolol Propanolol; Propranolol; Propranolol Hydrochloride; | 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 158, 167, 215, 227, 278, 296 |
421 |
Protamine hydrochloride
| - | 0件: | - | - | - |
422 |
Protriptyline
| - | 0件: | - | - | - |
423 |
Proxymetacaine
| - | 0件: | - | - | - |
424 |
Pseudoephedrine
| 1件: Pseudoephedrine Pseudoephedrine | 1件: Pseudoephedrine Pseudoephedrine; | 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
425 |
Pyrantel
| - | 0件: | - | - | - |
426 |
Pargyline
| - | 0件: | - | - | - |
427 |
Pyridoxine
| 1件: Pyridoxine Pyridoxine | 2件: PYRIDOXINE PYRIDOXINE; Vitamin B6; | - | - | 5件: 6 6, 93, 145, 206, 320 |
428 |
Perampanel
| 1件: Perampanel Perampanel | 2件: Fycompa Fycompa; Perampanel; | 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 3件: 2 2, 6, 144 |
429 |
Picoplatin
| - | 0件: | - | - | - |
430 |
Plerixafor
| 1件: Plerixafor Plerixafor | 2件: Mozobil Mozobil; PLERIXAFOR; | 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 6件: 19 19, 20, 51, 65, 285, 299 |
431 |
Pomalidomide
| 1件: Pomalidomide Pomalidomide | 3件: Imnovid Imnovid; Pomalidomida; Pomalidomide; | 2件: IL6 IL6, TNF 💬 | 80件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 6件: 28 28, 34, 51, 85, 227, 331 |
432 |
Pralnacasan
| - | 0件: | - | - | - |
433 |
Prucalopride
| 1件: Prucalopride Prucalopride | 2件: Prucalopride Prucalopride; Resolor; | 1件: HTR4 HTR4 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | 3件: 13 13, 51, 96 |
434 |
Pepper
| - | 0件: | - | - | - |
435 |
Pegloticase
| - | 0件: | - | - | - |
436 |
Palifosfamide
| - | 0件: | - | - | - |
437 |
Palovarotene
| 1件: Palovarotene Palovarotene | 1件: PALOVAROTENE PALOVAROTENE; | 1件: RARG RARG 💬 | - | 1件: 272 272 |
438 |
Pozanicline
| - | 0件: | - | - | - |
439 |
Pardoprunox
| 1件: Pardoprunox Pardoprunox | 1件: Pardoprunox Pardoprunox; | 3件: DRD2 DRD2, DRD3, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
440 |
Plinabulin
| - | 0件: | - | - | - |
441 |
Preladenant
| 1件: Preladenant Preladenant | 1件: Preladenant Preladenant; | 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
442 |
Pegdinetanib
| - | 0件: | - | - | - |
443 |
Peginesatide
| 1件: Peginesatide Peginesatide | 2件: Hematide Hematide; Peginesatide; | 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 |
444 |
Plecanatide
| - | 0件: | - | - | - |
445 |
Ponatinib
| - | 0件: | - | - | - |
446 |
Ponezumab
| - | 0件: | - | - | - |
447 |
Pridopidine
| 1件: Pridopidine Pridopidine | 1件: Pridopidine Pridopidine; | 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 8 |
448 |
Pexacerfont
| - | 0件: | - | - | - |
449 |
Pexelizumab
| - | 0件: | - | - | - |
450 |
Pegadricase
| - | 0件: | - | - | - |
451 |
Peginterferon lambda-1a
| - | 0件: | - | - | - |
452 |
Pasireotide
| 1件: Pasireotide Pasireotide | 3件: Pasireotida Pasireotida; PASIREOTIDE; SIGNIFOR; | 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 67 67, 74, 75 |
453 |
Patiromer
| - | 0件: | - | - | - |
454 |
Plazomicin
| - | 0件: | - | - | - |
455 |
Pateclizumab
| 1件: Pateclizumab Pateclizumab | 1件: MLTA3698A MLTA3698A; | 1件: LTA LTA 💬 | 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
456 |
Pictilisib
| - | 0件: | - | - | - |
457 |
Panobinostat
| - | 0件: | - | - | - |
458 |
Placulumab
| - | 0件: | - | - | - |
459 |
Patidegib
| - | 0件: | - | - | - |
460 |
Palbociclib
| - | 0件: | - | - | - |
461 |
Pidilizumab
| - | 0件: | - | - | - |
462 |
Pevonedistat
| - | 0件: | - | - | - |
463 |
Pimasertib
| - | 0件: | - | - | - |
464 |
Peginterferon beta-1a
| 1件: Peginterferon beta-1a Peginterferon beta-1a | 2件: PEGINTERFERON BETA-1A PEGINTERFERON BETA-1A; Plegridy; | 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
465 |
Pegnivacogin
| - | 0件: | - | - | - |
466 |
Pexastimogene devacirepvec
| - | 0件: | - | - | - |
467 |
Phenibut
| - | 0件: | - | - | - |
468 |
Paraoxon
| - | 0件: | - | - | - |
469 |
Pefcalcitol
| - | 0件: | - | - | - |
470 |
Pembrolizumab
| 1件: Pembrolizumab Pembrolizumab | 1件: Pembrolizumab Pembrolizumab; | 1件: PDCD1 PDCD1 💬 | 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 2件: 25 25, 285 |
471 |
Paritaprevir
| - | 0件: | - | - | - |
472 |
Peficitinib
| 1件: Peficitinib Peficitinib | 1件: Peficitinib Peficitinib; | 3件: JAK1 JAK1, JAK2, JAK3 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 |
473 |
Polmacoxib
| - | 0件: | - | - | - |
474 |
Pradigastat
| - | 0件: | - | - | - |
475 |
Pemafibrate
| 1件: Pemafibrate Pemafibrate | 1件: Pemafibrate Pemafibrate; | 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 |
476 |
Pretomanid
| - | 0件: | - | - | - |
477 |
Pitolisant
| 1件: Pitolisant Pitolisant | 1件: Pitolisant Pitolisant; | 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 113, 193 |
478 |
Polatuzumab vedotin
| - | 0件: | - | - | - |
479 |
Panax notoginseng root
| - | 0件: | - | - | - |
480 |
Plevitrexed
| - | 0件: | - | - | - |
481 |
Pibrentasvir
| - | 0件: | - | - | - |
482 |
Pomaglumetad methionil
| - | 0件: | - | - | - |
483 |
Pamrevlumab
| 1件: Pamrevlumab Pamrevlumab | 1件: PAMREVLUMAB PAMREVLUMAB; | 1件: CCN2 CCN2 💬 | 2件: Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | 2件: 85 85, 113 |
484 |
Pegapamodutide
| - | 0件: | - | - | - |
485 |
Piclidenoson
| 1件: Piclidenoson Piclidenoson | 1件: Piclidenoson Piclidenoson; | 1件: ADORA3 ADORA3 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
486 |
Plozalizumab
| - | 0件: | - | - | - |
487 |
Padeliporfin
| - | 0件: | - | - | - |
488 |
Pegteograstim
| - | 0件: | - | - | - |
489 |
Plitidepsin
| - | 0件: | - | - | - |
490 |
Pegvaliase
| 1件: Pegvaliase Pegvaliase | 3件: Palynziq Palynziq; PEGVALIASE; RAvPAL-PEG; | 1件: PAH PAH 💬 | 5件: Biosynthesis of amino acids Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬 | 1件: 240 240 |
491 |
Patisiran
| - | 0件: | - | - | - |
492 |
Pegilodecakin
| - | 0件: | - | - | - |
493 |
Pegvorhyaluronidase alfa
| - | 0件: | - | - | - |
494 |
Prexasertib
| - | 0件: | - | - | - |
495 |
Ponesimod
| 1件: Ponesimod Ponesimod | 1件: PONESIMOD PONESIMOD; | 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
496 |
Presatovir
| - | 0件: | - | - | - |
497 |
Pexidartinib
| 1件: Pexidartinib Pexidartinib | 1件: Turalio Turalio; | 3件: CSF1R CSF1R, FLT3, KIT 💬 | 15件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 34 34 |
498 |
Praliciguat
| - | 0件: | - | - | - |
499 |
Pimodivir
| - | 0件: | - | - | - |
500 |
Pavinetant
| - | 0件: | - | - | - |
501 |
Petesicatib
| - | 0件: | - | - | - |
502 |
Pemigatinib
| - | 0件: | - | - | - |
503 |
Prasinezumab
| 1件: Prasinezumab Prasinezumab | 1件: Prasinezumab Prasinezumab; | 1件: SNCA SNCA 💬 | 3件: Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
504 |
Pamiparib
| - | 0件: | - | - | - |
505 |
Parsaclisib
| 1件: Parsaclisib Parsaclisib | 2件: INCB050465 INCB050465; Parsaclisib; | 1件: PIK3CD PIK3CD 💬 | 106件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 3件: 35 35, 53, 61 |
506 |
Pepinemab
| - | 0件: | - | - | - |
507 |
Pozelimab
| 1件: Pozelimab Pozelimab | 1件: Pozelimab Pozelimab; | 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 11 11, 62 |
508 |
Pegcantratinib
| - | 0件: | - | - | - |
509 |
Pegbelfermin
| - | 0件: | - | - | - |
510 |
Pegcetacoplan
| 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan Pegcetacoplan; | 1件: C3 C3 💬 | 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 3件: 2 2, 62, 222 |
511 |
Pegunigalsidase alfa
| 1件: Pegunigalsidase alfa Pegunigalsidase alfa | 1件: PEGUNIGALSIDASE ALFA PEGUNIGALSIDASE ALFA; | - | - | 1件: 19 19 |
512 |
Pegzilarginase
| - | 0件: | - | - | - |
513 |
Pralsetinib
| - | 0件: | - | - | - |
514 |
Pacritinib
| - | 0件: | - | - | - |
515 |
Pabinafusp alfa
| 1件: Pabinafusp alfa Pabinafusp alfa | 1件: Pabinafusp alfa Pabinafusp alfa; | 2件: IDS IDS, TFRC 💬 | 8件: Endocytosis Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬 | 1件: 19 19 |
516 |
Padsevonil
| 1件: Padsevonil Padsevonil | 1件: Padsevonil Padsevonil; | 3件: SV2A SV2A, SV2B, SV2C 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 149 149 |
517 |
Pimivalimab
| - | 0件: | - | - | - |
518 |
Plasminogen
| - | 0件: | - | - | - |
519 |
Patritumab
| - | 0件: | - | - | - |
520 |
Poziotinib
| - | 0件: | - | - | - |
521 |
Pafolacianine
| - | 0件: | - | - | - |